Full-Time

Vice President

Patient Services

Deadline 2/26/27
Mercalis

Mercalis

1,001-5,000 employees

Life sciences commercialization, analytics, and partnerships

No salary listed

Louisville, KY, USA

In Person

Category
Operations & Logistics (1)
Requirements
  • Bachelor’s degree in Healthcare Administration, Business, or related field required; MBA, MHA, or related advanced degree preferred.
  • 10+ years of progressive leadership experience in patient support services, HUB operations, specialty pharmacy, or pharma services.
  • Proven success leading large-scale, multi-client programs in a third-party HUB or outsourced services environment.
  • Deep understanding of patient access, reimbursement models, and the pharmaceutical commercialization process.
  • Demonstrated experience managing client relationships at the executive level.
  • Strong leadership, financial acumen, and operational management skills.
  • Commitment to service excellence, innovation, and compliance integrity.
Responsibilities
  • Define and execute the strategic vision for HUB operations and patient support services across multiple biopharma partnerships.
  • Serve as a senior strategic partner to clients, ensuring alignment between program design, brand strategy, and operational delivery.
  • Identify new opportunities to expand and enhance service offerings, including technology integration, digital engagement, and patient insights.
  • Collaborate with Business Development and Program Implementation teams to support new client onboarding, RFP responses, and program launches.
  • Lead all aspects of HUB operations, including benefits verification, prior authorization, financial assistance, patient onboarding, adherence programs, and nursing/clinical support (as applicable).
  • Establish and monitor performance metrics, ensuring achievement of client SLAs, KPIs, and quality standards.
  • Drive continuous improvement initiatives that increase efficiency, scalability, and patient satisfaction.
  • Partner with Technology and Analytics teams to leverage data insights for proactive decision-making and performance optimization.
Desired Qualifications
  • MBA, MHA, or related advanced degree preferred

Mercalis provides commercialization services for life sciences and pharmaceutical companies. It uses data analytics, industry expertise, and technology to maximize value across both product and patient journeys, guiding from value discovery to delivery. Its offerings include insights, strategy, data, and solutions that help life sciences leaders address critical business issues and support strategic decision-making. The company also connects patients with life sciences products and programs through data-driven access initiatives, and it conducts scalable outreach to healthcare providers to generate leads, educate, and engage across the provider value chain. By focusing on partnerships with life sciences companies, Mercalis aims to unlock product value and improve patient lives.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Morrisville, North Carolina

Founded

N/A

Simplify Jobs

Simplify's Take

What believers are saying

  • PharmaCord merger enhances patient access with combined expertise.
  • U.S. court vacated 2023 CMS rule, preserving copay programs.
  • Philanthropic partnerships boost Mercalis's community reputation.

What critics are saying

  • PharmaCord integration fails, cutting staff and service quality in 6-12 months.
  • IQVIA One Home diverts 20-30% of contracts in 12-18 months.
  • CoverMyMeds blocks eServices growth, halving new clients in 12-24 months.

What makes Mercalis unique

  • Mercalis integrates Policy Reporter for real-time market access data.
  • Mercalis combines patient services with advanced commercialization technology.
  • Mercalis rebranded from TrialCard, serving 500+ life sciences customers since 2000.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Mercalis who can refer or advise you

Benefits

Remote Work Options

Professional Development Budget

Training Programs

Company News

PR Newswire
Apr 3rd, 2025
Triangle Insights Group By Mercalis Announces Promotion Of Parker Guse

Premier life sciences consulting firm promotes Senior Principal to PartnerDURHAM, N.C., April 3, 2025 /PRNewswire/ -- Triangle Insights Group by Mercalis (Triangle), a premier strategy consulting firm that delivers high-impact solutions across the life sciences value chain, today announced a promotion that recognizes high achievement and further strengthens the firm's senior leadership team. Triangle, acquired by life sciences commercialization company Mercalis in April 2022, has named Parker Guse a Partner.Guse, who joined Triangle in June 2014, has over a decade of experience in the life sciences industry. In his role, Parker leads Triangle's business development and corporate strategy center of excellence. He has extensive experience in both buy-side and sell-side diligence that spans pharma, biotech, and private equity clients. His typical projects include due diligence, commercial assessment, and portfolio and commercialization strategy. Guse has been involved in over 300 projects spanning all therapeutic areas, with a focus on oncology, autoimmune disorders, and rare diseases.Guse holds a BA in Economics from the University of North Carolina at Chapel Hill."Parker has made invaluable contributions to Triangle's success throughout his years at the firm," said Megan Thomas, Triangle's General Manager

Business Wire
Mar 13th, 2025
PharmaCord and Mercalis to Merge, Creating Next-Generation Platform to Meet Evolving Needs of the Biopharmaceutical Industry

PharmaCord LLC (“PharmaCord”), a leading provider of patient services for the biopharmaceutical industry, and Mercalis, an integrated life sciences co

Permira
Mar 12th, 2025
PharmaCord and Mercalis to Merge, Creating Next-Generation Platform to Meet Evolving Needs of the Biopharmaceutical Industry

By combining PharmaCord's expertise in patient services with Mercalis's advanced technology infrastructure, experienced commercial team, and fully integrated market access offerings, the new entity is poised to be a leading provider of patient access solutions to the biopharmaceutical industry.